Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experience
Lutrino, Eufemia S., Orlando, Laura, Febbraro, Antonio, Giampaglia, Marianna, Zamagni, Claudio, Schiavone, Paola, Scavelli, Claudio, Dima, Gianluca, Fedele, Palma, Giordano, Guido, Bilancia, Domenico, Quaranta, Anna Maria, Rubino, Daniela, Filippelli, Gianfranco, Fontanella, Caterina, Caliolo, Chiara, Marino, Antonella, Calvani, Nicola, Ferrara, Pasqualinda, Cinieri, Saverio
Published in Tumori (01.08.2020)
Published in Tumori (01.08.2020)
Get full text
Journal Article
Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review
Leporini, Christian, Saullo, Francesca, Filippelli, Gianfranco, Sorrentino, Antonio, Lucia, Maria, Perri, Gino, Gattuta, Gaetana La, Infusino, Stefania, Toscano, Rosa, Dima, Gianluca, Olivito, Virginia, Paletta, Laura, Bottoni, Ugo, De Sarro, Giovambattista
Published in Journal of pharmacology & pharmacotherapeutics (01.12.2013)
Published in Journal of pharmacology & pharmacotherapeutics (01.12.2013)
Get full text
Journal Article
Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review
Leporini, Christian, Saullo, Francesca, Filippelli, Gianfranco, Sorrentino, Antonio, Lucia, Maria, Perri, Gino, Gattuta, Gaetana La, Infusino, Stefania, Toscano, Rosa, Dima, Gianluca, Olivito, Virginia, Paletta, Laura, Bottoni, Ugo, De Sarro, Giovambattista
Published in Journal of pharmacology & pharmacotherapeutics (01.12.2013)
Published in Journal of pharmacology & pharmacotherapeutics (01.12.2013)
Get full text
Report